Bigul

Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended March 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Haresh MehtaDesignation :- Managing Director / Whole Time Director
16-04-2020
Bigul

Medico Remedies Ltd - 540937 - Closure of Trading Window

Re.: Notice for Closure of Trading Window We hereby inform you that in terms of Company's Code for Prevention of Insider Trading framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in equity shares of the Company shall be closed for all Insiders, Directors, Officers, Designated employees and their immediate relatives of the Company from 1st April, 2020 upto the expiry of 48 hours post the date of declaration of the financial results for the half year and year ended 31st March, 2020. Kindly take the same on record.
31-03-2020
Bigul

Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Haresh MehtaDesignation :- Director
13-01-2020
Bigul

Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Haresh MehtaDesignation :- Director
13-01-2020
Bigul

Medico Remedies Ltd - 540937 - Un-Audited Financial Results Of The Company For The Half Year Ended On 30Th September, 2019

Un-audited Financial Results of the Company for the half year ended on 30th September, 2019. The Board has approved Unaudited Financial Results for the half year ended 30th September, 2019 along with the Limited Review Report thereon. We wish to inform you that the Board Meeting commenced today at 1.00 P.M and concluded at 4.00 P.M Kindly take the same on record and oblige.
13-11-2019
Bigul

Medico Remedies Ltd - 540937 - Outcome of Board Meeting

Outcome of the Board Meeting held today Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that at the Meeting of Board of Directors of our Company held today i.e. 13th November, 2019 has, inter alia considered and approved the following: 1. Un-audited Financial Results of the Company for the half year ended on 30th September, 2019. The Board has approved Unaudited Financial Results for the half year ended 30th September, 2019 along with the Limited Review Report thereon. We wish to inform you that the Board Meeting commenced today at 1.00 P.M and concluded at 4.00 P.M Kindly take the same on record and oblige.
13-11-2019
Bigul

Medico Remedies Ltd - 540937 - Board Meeting Intimation for Notice Of The Board Meeting

Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve We hereby inform you that a meeting of the Board of Directors of the Company will be held on 13th November 2019, inter alia, to transact the following business: 1. To consider and approve, the Unaudited Financial Results for the Half Year ended September 30, 2019 along with the Limited Review Report thereon; and 2. Any other business with the permission of the Chair Kindly take the same on record.
05-11-2019
Bigul

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Resignation of Director

Dear Sir/Madam, Pursuant to Regulation 30 read with PART A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we hereby inform that Mrs. Shweta Harshit Mehta (DIN: 07121215) has resigned from the post of Wholetime Director w.e.f 23rd October, 2019. Kindly take the same on record Thanking You
23-10-2019
Bigul

Medico Remedies Ltd - 540937 - Shareholding for the Period Ended September 30, 2019

Medico Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
19-10-2019
Next Page
Close

Let's Open Free Demat Account